LINC00205
gene geneOn this page
Also known as LVBU
Summary
LINC00205 (long intergenic non-protein coding RNA 205, HGNC:16420) is a long non-coding RNA gene on chromosome 21q22.3.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16420 |
| Approved symbol | LINC00205 |
| Name | long intergenic non-protein coding RNA 205 |
| Location | 21q22.3 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | LVBU |
| Ensembl gene | ENSG00000223768 |
| Ensembl biotype | lncRNA |
| Entrez | 642852 |
| RNAcentral | URS000075D064 — lncRNA, 7181 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 24 — 24 lncRNA
ENST00000400362, ENST00000433465, ENST00000454115, ENST00000647108, ENST00000652705, ENST00000689879, ENST00000701789, ENST00000716679, ENST00000716680, ENST00000716681, ENST00000716682, ENST00000716687, ENST00000757150, ENST00000757151, ENST00000757152, ENST00000757153, ENST00000757154, ENST00000757155, ENST00000757156, ENST00000757157, ENST00000757158, ENST00000757159, ENST00000757160, ENST00000757161
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000400362 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001714446 | 45289351 | 45289438 |
| ENSE00004107950 | 45290471 | 45297806 |
| ENSE00004107951 | 45287983 | 45288165 |
Expression profiles
Bgee: expression breadth ubiquitous, 223 present calls, max score 96.57.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 12.0829 / max 160.4835, expressed in 1745 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 189540 | 12.0829 | 1745 |
Top tissues by expression
253 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| endothelial cell | CL:0000115 | 96.57 | gold quality |
| cortical plate | UBERON:0005343 | 95.25 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 93.12 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 90.48 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 89.96 | gold quality |
| ganglionic eminence | UBERON:0004023 | 89.65 | gold quality |
| tibia | UBERON:0000979 | 89.02 | gold quality |
| ventricular zone | UBERON:0003053 | 88.83 | gold quality |
| hypothalamus | UBERON:0001898 | 88.41 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 87.96 | gold quality |
| adrenal tissue | UBERON:0018303 | 87.86 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 87.20 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 87.09 | gold quality |
| entorhinal cortex | UBERON:0002728 | 86.98 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 85.81 | gold quality |
| right frontal lobe | UBERON:0002810 | 85.72 | gold quality |
| temporal lobe | UBERON:0001871 | 85.61 | gold quality |
| amygdala | UBERON:0001876 | 85.50 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 85.40 | gold quality |
| cerebral cortex | UBERON:0000956 | 85.22 | gold quality |
| left ovary | UBERON:0002119 | 85.21 | gold quality |
| Ammon’s horn | UBERON:0001954 | 85.19 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 85.16 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 85.07 | gold quality |
| cerebellar cortex | UBERON:0002129 | 84.91 | gold quality |
| neocortex | UBERON:0001950 | 84.73 | gold quality |
| primary visual cortex | UBERON:0002436 | 84.65 | gold quality |
| cerebellum | UBERON:0002037 | 84.45 | gold quality |
| forebrain | UBERON:0001890 | 84.04 | gold quality |
| right ovary | UBERON:0002118 | 84.00 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.62 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 8)
- LINC00205 acted as a competing endogenous RNA by directly interacting with miR-122-5p in hepatocellular carcinoma (PMID:31272761)
- LINC00205 modulates the expression of EPHX1 through the inhibition of miR-184 in hepatocellular carcinoma as a ceRNA. (PMID:31566711)
- Long noncoding RNA LINC00205 enhances the malignant characteristics of retinoblastoma by acting as a molecular sponge of microRNA-665 and consequently increasing HMGB1 expression. (PMID:32223925)
- LINC00205 promotes malignancy in lung cancer by recruiting FUS and stabilizing CSDE1. (PMID:32808651)
- LINC00205 Promotes Tumor Malignancy of Lung Adenocarcinoma Through Sponging miR-185-5p. (PMID:34270733)
- LINC00205, a YY1-modulated lncRNA, serves as a sponge for miR-26a-5p facilitating the proliferation of hepatocellular carcinoma cells by elevating CDK6. (PMID:34730201)
- Long non-coding RNA Linc00205 promotes hepatoblastoma progression through regulating microRNA-154-3p/Rho-associated coiled-coil Kinase 1 axis via mitogen-activated protein kinase signaling. (PMID:35179516)
- LncRNA LINC00205 stimulates osteoporosis and contributes to spinal fracture through the regulation of the miR-26b-5p/KMT2C axis. (PMID:37016415)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.